NCT02633527: Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD
- State
- Completed
- Phase
- Phase 2
- People
- 222 taking part
- Started
- 1 Feb 2016
- Primary completion
- 25 Jul 2016
- Arms
- 100mg SPN-812, 200mg SPN-812, 300mg SPN-812, 400mg SPN-812
- Results
- Posted on the registry
- 17 Dec 2015: Trial registered
- 1 Feb 2016: Trial started
- 25 Jul 2016: Trial completed
- 27 Oct 2021: Trial results posted